Insider trade

Stryker Corporation (SYK)Director sold ~$37.8M

Ronda E Stryker, Director at Stryker Corporation, sold ~$37.8M of Stryker Corporation shares.

~$37.8M
Approx. value · 97K sh @ $390.89
3.75M
Holds after · shares reported
Traded
Jan 31, 2025
Filed
Feb 5, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Feb 2, 2023InsiderOfficer sold ~$211K of SYK shares in the open market
  2. Jan 15, 2025Congress · 1 personMembers of Congress: 2 purchases
  3. Jan 31, 2025 · this disclosureInsiderDirector sold ~$37.8M of SYK shares in the open market

What came next

  1. Jan 31, 2025Insider · 1 personInsiders: 6 sales (~$54.9M)
  2. Feb 18, 2025InsiderDirector sold ~$942K of SYK shares in the open market
  3. Feb 26, 2025CongressDisclosed partial sale of SYK — reported range $15,001 - $50,000
  4. Feb 28, 2025FDARecall: Monterey AL Implant Inserter; 14/16mm; Catalog 48019120.
  5. Feb 28, 2025FDARecall: Monterey AL Implant Inserter; 10/12mm; Catalog 48019100.
  6. Mar 11, 2025FDAFDA device clearance: iBur 3.0mm Diamond Match Head, Distal Bend (8431-107-030D); iBur 3.0mm Precision Round, Distal Bend (8431-009-030); iBur 4.0mm Precision Round, Distal Bend (84…
  7. Mar 13, 2025CongressDisclosed partial sale of SYK — reported range $50,001 - $100,000
  8. Mar 21, 2025FDAFDA device clearance: Excelsior XT-27 Microcatheter, Excelsior XT-27 Flex Microcatheter, Excelsior XT-27 Pre-Shaped Microcatheter, Excelsior XT-27 Flex Pre-Shaped Microcatheter
  9. Mar 21, 2025FDAFDA device clearance: Consolidated Operating Room Equipment (CORE) 2 Console
  10. Mar 24, 2025FDAFDA device clearance: Sonopet iQ Ultrasonic Aspirator System (5500-050-000)
  11. Mar 28, 2025FDARecall: Guide Wire with Ruler Tube 3x800 mm DIA; Catalog number/REF: 2351-3080S;
  12. Mar 28, 2025FDARecall: Guide Wire with Ruler Tube 3x1000 mm DIA; Catalog number/REF: 2351-3100S;
  13. Apr 7, 2025Congress · 2 peopleMembers of Congress: 1 purchase, 1 sale
  14. Apr 8, 2025Congress · 1 personMembers of Congress: 2 sales
  15. Apr 15, 2025FDAFDA device clearance: OptaBlate Radiofrequency (RF) Generator System
  16. Apr 17, 2025CongressDisclosed purchase of SYK — reported range $15,001 - $50,000
  17. May 6, 2025Insider · 1 personInsiders: 6 sales (~$75.4M)
  18. May 12, 2025InsiderOfficer sold ~$482K of SYK shares in the open market
  19. May 15, 2025FDAFDA device clearance: OptaBlate BVN Intraosseous Nerve Ablation System (10mm Probe Single Kit); OptaBlate BVN Intraosseous Nerve Ablation System (10mm Probe Dual Kit)
  20. May 21, 2025FDAFDA device clearance: Stryker AlphaVent™ Knotless SP Biocomposite Anchor
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Stryker Corporation

For Stryker Corporation, OQRO holds 27 insider filings (SEC Form 4 or Form 144), 3 Congress trade reports, 67 fund holdings reports (13F) and 3 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its SYK page.

Other recent filings by Ronda E Stryker, Director

The full history of Ronda E Stryker, Director is on the profile page.

How this filing works

Other disclosures at Stryker Corporation

Everything OQRO holds on this company is on its SYK page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data